|Bid||1.59 x 100|
|Ask||2.81 x 300|
|Day's Range||1.63 - 1.71|
|52 Week Range||1.40 - 13.20|
|PE Ratio (TTM)||-0.18|
|Earnings Date||Aug 21, 2017 - Aug 23, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||24.00|
PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / August 4, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate ...
-Demonstrates 95% Negative Predictive Value (NPV) in a Population with High Malignancy Rate; Confirms High NPV Shown in Earlier Reveal Validation Study -Results Highlighted in Oral Presentation at the ...
Survey of Clinical Use Demonstrates Potential for Significant Reduction in Unnecessary Surgeries Associated with Indeterminate Thyroid Nodules PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / July 26, ...